A silica-based pH-sensitive nanomatrix system improves the oral absorption and efficacy of incretin hormone glucagon-like peptide-1

References

• WildSRoglicGGreenASicreeRKingHGlobal prevalence of diabetes: estimates for the year 2000 and projections for 2030Diabetes Care20042751047105315111519
   PubMed Web of Science ®Google Scholar
• RoglicGUnwinNBennettPHThe burden of mortality attributable to diabetes: realistic estimates for the year 2000Diabetes Care20052892130213516123478
   PubMed Web of Science ®Google Scholar
• HolstJJGut hormones as pharmaceuticals. From enteroglucagon to GLP-1 and GLP-2Regul Pept2000931–3455111033052
   PubMedGoogle Scholar
• SiegelEGGallwitzBScharfGBiological activity of GLP-1-analogues with N-terminal modificationsRegul Pept1999792–39310210100921
   PubMedGoogle Scholar
• DeaconCFJohnsenAHHolstJJDegradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivoJ Clin Endocrinol Metab19958039529577883856
   PubMed Web of Science ®Google Scholar
• EdwardsCMStanleySADavisRExendin-4 reduces fasting and postprandial glucose and decreases energy intake in healthy volunteersAm J Physiol Endocrinol Metab20012811E155E16111404233
   PubMed Web of Science ®Google Scholar
• JuhlCBHollingdalMSturisJBedtime administration of NN2211, a long-acting GLP-1 derivative, substantially reduces fasting and postprandial glycemia in type 2 diabetesDiabetes200251242442911812750
   PubMed Web of Science ®Google Scholar
• HolstJJDeaconCFInhibition of the activity of dipeptidyl-peptidase IV as a treatment for type 2 diabetesDiabetes19984711166316709792533
   PubMed Web of Science ®Google Scholar
• ChoiSBaudysMKimSWControl of blood glucose by novel GLP-1 delivery using biodegradable triblock copolymer of PLGA-PEG-PLGA in type 2 diabetic ratsPharm Res200421582783115180341
   PubMed Web of Science ®Google Scholar
• GedulinBRSmithPAJodkaCMPharmacokinetics and pharmacodynamics of exenatide following alternate routes of administrationInt J Pharm20083561–223123818291606
   PubMed Web of Science ®Google Scholar
• LimSBRubinsteinIOnyükselHFreeze drying of peptide drugs self-associated with long-circulating, biocompatible and biodegradable sterically stabilized phospholipid nanomicellesInt J Pharm20083561–234535018289811
   PubMed Web of Science ®Google Scholar
• SinghRLillardJWJrNanoparticle-based targeted drug deliveryExp Mol Pathol200986321522319186176
   PubMed Web of Science ®Google Scholar
• KesisoglouFPanmaiSWuYNanosizing – oral formulation development and biopharmaceutical evaluationAdv Drug Deliv Rev200759763164417601629
   PubMed Web of Science ®Google Scholar
• JunghannsJUMüllerRHNanocrystal technology, drug delivery and clinical applicationsInt J Nanomedicine20083329530918990939
   PubMed Web of Science ®Google Scholar
• MüllerRHKeckCMChallenges and solutions for the delivery of biotech drugs – a review of drug nanocrystal technology and lipid nanoparticlesJ Biotechnol20041131–315117015380654
   PubMed Web of Science ®Google Scholar
• GascoMRLipid nanoparticles: perspectives and challengesAdv Drug Deliv Rev200759637737817582649
   PubMed Web of Science ®Google Scholar
• MehnertWMäderKSolid lipid nanoparticles: production, characterization and applicationsAdv Drug Deliv Rev2001472–316519611311991
   PubMed Web of Science ®Google Scholar
• HosseinkhaniHDNA nanoparticles for gene delivery to cells and tissueInt J Nanomedicine200634416461
   Google Scholar
• HosseinkhaniHTabataYSelf assembly of DNA nanoparticles with polycations for the delivery of genetic materials into cellsJ Nanosci Nanotechnol2006682320232817037837
   PubMed Web of Science ®Google Scholar
• HosseinkhaniHHosseinkhaniMBiodegradable polymer-metal complexes for gene and drug deliveryCurr Drug Saf200941798319149528
   PubMedGoogle Scholar
• SubramaniaKPathakSHosseinkhaniHRecent trends in diabetes treatment using nanotechnologyDigest Journal of Nanomaterials and Biostructures2012718595
   Web of Science ®Google Scholar
• FriedrichHFussneggerBKolterKBodmeierRDissolution rate improvement of poorly water-soluble drugs obtained by adsorbing solutions of drugs in hydrophilic solvents onto high surface area carriersEur J Pharm Biopharm200;622171177
   Web of Science ®Google Scholar
• JiaZLinPXiangYA novel nanomatrix system consisted of colloidal silica and pH-sensitive polymethylacrylate improves the oral bioavailability of fenofibrateEur J Pharm Biopharm201179112613421658449
   PubMed Web of Science ®Google Scholar
• BarrettEPJoynerLGHalendaPPThe determination of pore volume and area distributions in porous substances. I. Computations from nitrogen isothermsJ Am Chem Soc1951731373380
   Web of Science ®Google Scholar
• YounYSJungJYOhSHYooSDLeeKCImproved intestinal delivery of salmon calcitonin by Lys18-amine specific PEGylation: stability, permeability, pharmacokinetic behavior and in vivo hypocalcemic efficacyJ Control Release2006114333434216884808
   PubMed Web of Science ®Google Scholar
• BraggioSFerraraASartoriMEvaluation of the role of intestinal and liver metabolism in the conversion of two different ester prodrugs of sanfetrinem to the parent drug in vitro and in vivo using different rat tissues and a surgically prepared rat modelEur J Pharm Sci2002161–2455112113890
   PubMed Web of Science ®Google Scholar
• BouërRBartheLPhilibertCTournaireCWoodleyJHouinGThe roles of P-glycoprotein and intracellular metabolism in the intestinal absorption of methadone: in vitro studies using the rat everted intestinal sacFundam Clin Pharmacol199913449450010456292
   PubMed Web of Science ®Google Scholar
• ClelandJLBarronLBermanPWDevelopment of a single-shot subunit vaccine for HIV-1. 2. Defining optimal autoboost characteristics to maximize the humoral immune responseJ Pharm Sci19968512134613498961151
   PubMed Web of Science ®Google Scholar
• LangerRClelandJLHanesJNew advances in microsphere-based single-dose vaccinesAdv Drug Deliv Rev19972819711910837567
   PubMed Web of Science ®Google Scholar
• DaiJNagaiTWangXZhangTMengMZhangQpH-sensitive nanoparticles for improving the oral bioavailability of cyclosporine AInt J Pharm20042801–222924015265562
   PubMed Web of Science ®Google Scholar
• ArturssonPBorchardtRTIntestinal drug absorption and metabolism in cell cultures: Caco-2 and beyondPharm Res19971412165516589453050
   PubMed Web of Science ®Google Scholar
• NgKYBorchardtRTBiotin transport in a human intestinal epithelial cell line (Caco-2)Life Sci19935314112111278371628
   PubMed Web of Science ®Google Scholar
• WangXQDaiJDZhangHZhangXWangJCZhangQAbsorption mechanism of cyclosporine A loaded pH-sensitive nanoparticles in ratsJ Nanosci Nanotechnol2008852422243118572658
   PubMed Web of Science ®Google Scholar
• HosseinkhaniMHosseinkhaniHChenYRSubramaniKIn vitro physicochemical evaluation of DNA nanoparticlesInternational Journal of Nanotechnology201188–9736748
   Web of Science ®Google Scholar
• HosseinkhaniHHosseinkhaniMGabrielsonNPPackDWKhademhosseiniAKobayashiHDNA nanoparticles encapsulated in 3D tissue-engineered scaffolds enhance osteogenic differentiation of mesenchymal stem cellsJ Biomed Mater Res A2008851476017688252
   PubMed Web of Science ®Google Scholar
• HosseinkhaniHAzzamTTabataYDombAJDextran-spermine polycation: an efficient nonviral vector for in vitro and in vivo gene transfectionGene Ther200411219420314712304
   PubMed Web of Science ®Google Scholar
• YounYSChaeSYLeeSKwonMJShinHJLeeKCImproved peroral delivery of glucagon-like peptide-1 by site-specific.biotin modification: design, preparation, and biological evaluationEur J Pharm Biopharm200868366767517904340
   PubMed Web of Science ®Google Scholar
• HanatoJKuriyamaKMizumotoTLiposomal formulations of glucagon-like peptide-1: improved bioavailability and anti-diabetic effectInt J Pharm20093821–211111619698772
   PubMed Web of Science ®Google Scholar